|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/52 | |||
| A61K 45/06 | |||
| A61K 31/422 | |||
| A61K 31/454 | |||
| A61K 31/4545 | |||
| A61K 31/496 | |||
| A61K 31/505 | |||
| A61P 25/14 | |||
| A61P 25/16 | |||
| A61K 9/28 |
| (11) | Patento numeris | 2838517 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13725557.6 |
| Europos patento paraiškos padavimo data | 2013-04-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/DK2013/050111 |
| Data | 2013-04-18 |
| (87) | Numeris | WO 2013/156035 |
| Data | 2013-10-24 |
| (30) | Numeris | Data | Šalis |
| 201270196 | 2012-04-18 | DK | |
| PCT/DK2012/0501 | 2012-06-01 | WO | |
| 201270755 | 2012-12-04 | DK |
| (72) |
HANSEN, John Bondo, DK
THOMSEN, Mikael S., DK
MIKKELSEN, Jens D., DK
NIELSEN, Peter Gudmund, DK
KREILGAARD, Mads, DK
|
| (73) |
Contera Pharma APS,
Ole Maal es Vej 3, 2200 Copenhagen N,
DK
|
| (54) | ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS |
| ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS |